Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Microbiome Clinical Studies Loom Large In 2018

Executive Summary

Events are moving fast in the microbiome field. The sector is expecting results from numerous initial clinical studies during 2018, from across a spectrum of approaches and mechanisms of action, which could lead to new rounds of financings and M&A activity.

Advertisement

Related Content

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019
Full Steam Ahead At Ferring To Unlock Microbiome Potential For Reproduction
Deal Watch: Millendo Completes Merger With OvaScience, With $85m In Bank For Two Mid-Stage Programs
Ferring Leapfrogs Into Late-Stage Microbiome Race With Rebiotix Buy
How Intract Is Helping Shape Microbiome-Based Therapies
Synthetic Biologics CEO On Pipeline Advances And The Microbiome
Pipeline Watch: Phase III Starts For Seres' SER-109, Leo's Tralokinumab And Alkermes' ALKS-5461
Second Genome CEO Predicts Paradigm Shift With Microbiome Discovery
Venture Funding Deals: Takeda Ups Its Bet On Immuno-Oncology Play Maverick
Microbiome Drug Developer Raises $50m For First-In-Human Studies

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC100142

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel